|
Unravel tumor profiles to advance precision oncology. See how homologous recombination deficiency (HRD) status of solid tumor samples was demonstrated using the Agilent SureSelect Cancer CGP assay, targeting 679 genes, with two commercial informatics solutions.
|
|
Get details about the SureSelect Cancer CGP Assay. For Research Use Only. Not for use in diagnostic procedures. |
||||
|
|